Prof. Dr. Bengül GÜNALP

1. Clinical behaviour of papillary thyroid cancer oncocytic variant: Stage-matched comparison versus classical and tall cell variant papillary thyroid cancer Comportamiento clínico de la variante oncocítica del cáncer papilar de tiroides: comparación de su evolución frente al cáncer papilar, variantes clásica y de células altas

OKUYUCU K., İNCE S., ÇINAR A. S., San H., Samsum M., Dizdar N., et al.

Revista Espanola de Medicina Nuclear e Imagen Molecular , cilt.42, sa.2, ss.100-105, 2023 (SCI-Expanded, Scopus)

2. Prognostic risk factors for rare oncocytic variant in 101 cases of papillary thyroid carcioma

ALAGÖZ E., OKUYUCU K., İNCE S., Mahmudov S., Ayan A., Demirci I., et al.

Hellenic Journal of Nuclear Medicine , cilt.22, sa.2, ss.116-122, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

3. Evaluation of predictor variables of diagnostic [18F] FDG-PET/CT in fever of unknown origin

OKUYUCU K., ALAGÖZ E., Demirbas S., İNCE S., Karakas A., KARAÇALIOĞLU A. Ö., et al.

Quarterly Journal of Nuclear Medicine and Molecular Imaging , cilt.62, sa.3, ss.313-320, 2018 (SCI-Expanded, Scopus)

4. Complementary role of parathormone washout test to 99m Tc-MIBI parathyroid scintigraphy and histopathologic analysis of cell types in parathyroid adenomas Gammagrafía paratiroidea con 99m Tc-MIBI: valor complementario de la paratohormona en el aspirado y análisis histopatológico de los tipos de células en los adenomas paratiroideos

İNCE S., Emer O., Deveci S., OKUYUCU K., ALAGÖZ E., San H., et al.

Revista Espanola de Medicina Nuclear e Imagen Molecular , cilt.37, sa.4, ss.205-210, 2018 (SCI-Expanded, Scopus)

5. Impact of tall cell variant histology on predicting relapse and changing the management of papillary thyroid carcinoma patients

GÜNALP B., OKUYUCU K., İNCE S., Ayan A., ALAGÖZ E.

Hellenic Journal of Nuclear Medicine , cilt.20, sa.2, ss.122-127, 2017 (SCI-Expanded, Scopus)

6. Risk factors and stratification for recurrence of patients with differentiated thyroid cancer, elevated thyroglobulin and negative I-131 whole-body scan, by restaging 18F-FDG PET/CT

OKUYUCU K., İNCE S., ALAGÖZ E., Emer O., San H., Balkan E., et al.

Hellenic Journal of Nuclear Medicine , cilt.19, sa.3, ss.208-217, 2016 (SCI-Expanded, Scopus)

7. Clinicopathologic features and prognostic factors of tall cell variant of papillary thyroid carcinoma: Comparison with classic variant of papillary thyroid carcinoma

OKUYUCU K., ALAGÖZ E., Arslan N., Emer O., İNCE S., Deveci S., et al.

Nuclear Medicine Communications , cilt.36, sa.10, ss.1021-1025, 2015 (SCI-Expanded, Scopus)

8. Evaluation of radiographic and metabolic changes in bone metastases in response to systemic therapy with18FDG-PET/CT

GÜNALP B., Oner A. O., İNCE S., ALAGÖZ E., Ayan A., Arslan N.

Radiology and Oncology , cilt.49, sa.2, ss.115-120, 2015 (SCI-Expanded, Scopus)

9. Clinical impact of 18F-FDG PET/CT on initial staging and therapy planning for breast cancer

GÜNALP B., İNCE S., KARAÇALIOĞLU A. Ö., Ayan A., Emer O., ALAGÖZ E.

Experimental and Therapeutic Medicine , cilt.4, sa.4, ss.693-698, 2012 (SCI-Expanded, Scopus)

10. The role of 18f-fluoro-2-deoxyglucose positron emission tomography imaging in thyroid cancers Tiroid kanserlerinde flor-18 florodeoksiglukoz pozitron emisyon tomografi görüntülemenin yeri

Emer M. Ö., ILGAN S., ALAGÖZ E., Arslan N., KARAÇALIOĞLU A. Ö., GÜNALP B., et al.

Gulhane Medical Journal , cilt.51, sa.4, ss.229-234, 2009 (Scopus, TRDizin)

11. Combined Tc-99m MDP and Tc-99m labeled RBC imaging in a case of Maffucci's syndrome

KARAÇALIOĞLU A. Ö., GÜNALP B., ILGAN S., Arslan N., Ozguven M. A.

Clinical Nuclear Medicine , cilt.29, sa.12, ss.817-820, 2004 (Scopus)

12. Iodine-131 treatment and high-resolution CT: Results in patients with lung metastases from differentiated thyroid carcinoma

ILGAN S., KARAÇALIOĞLU A. Ö., Pabuscu Y., Atac G. K., Arslan N., Ozturk E., et al.

European Journal of Nuclear Medicine and Molecular Imaging , cilt.31, sa.6, ss.825-830, 2004 (SCI-Expanded, Scopus)

Prof. Dr. Bengül GÜNALP

Yayınlar & Eserler

2. Prognostic risk factors for rare oncocytic variant in 101 cases of papillary thyroid carcioma

3. Evaluation of predictor variables of diagnostic [18F] FDG-PET/CT in fever of unknown origin

5. Impact of tall cell variant histology on predicting relapse and changing the management of papillary thyroid carcinoma patients

6. Risk factors and stratification for recurrence of patients with differentiated thyroid cancer, elevated thyroglobulin and negative I-131 whole-body scan, by restaging 18F-FDG PET/CT

7. Clinicopathologic features and prognostic factors of tall cell variant of papillary thyroid carcinoma: Comparison with classic variant of papillary thyroid carcinoma

8. Evaluation of radiographic and metabolic changes in bone metastases in response to systemic therapy with18FDG-PET/CT

9. Clinical impact of 18F-FDG PET/CT on initial staging and therapy planning for breast cancer

10. The role of 18f-fluoro-2-deoxyglucose positron emission tomography imaging in thyroid cancers Tiroid kanserlerinde flor-18 florodeoksiglukoz pozitron emisyon tomografi görüntülemenin yeri

11. Combined Tc-99m MDP and Tc-99m labeled RBC imaging in a case of Maffucci's syndrome

12. Iodine-131 treatment and high-resolution CT: Results in patients with lung metastases from differentiated thyroid carcinoma

Yayın

Yayın (WoS)

Yayın (Scopus)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Tez Danışmanlığı